Medicilon Congratulates : MindRank AI-Developed Oral GLP-1 MDR-001 Secures Up to RMB 1.75 Billion Exclusive Commercialization Deal with Sunshine Mandi

September 28 — MindRank AI Ltd. (“MindRank”) today announced that it has entered into a strategic commercialization agreement with Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd. (“Sunshine Mandi”) and Zhejiang Wansheng Pharmaceutical Co., Ltd. (“Wansheng”), both subsidiaries of 3SBio Inc. (01530.HK) group, for MDR-001, an AI-designed oral small-molecule GLP-1 receptor agonist in a pivotal Phase 3 […]